SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

AUROBINDO PHARMA

BSE: 524804 19 Aug 2025
Healthcare
₹ 1090.3
Aurobindo Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

AUROBINDO PHARMA - Share Price & Details

Market Cap
₹63,984
High /Low
1,593 / 994.0
Stock P/E
19.0
Book Value
₹557.0
Dividend Yield
0.41
ROCE
14.2
ROE
₹11.1
Face Value
1.0
PEG Ratio
2.4
EVEBITDA
₹9.09
Debt
8,263
CMP / FCF
10,292
Debt to equity
₹0.25
NP Ann
3,484
High price all time
1,593
Piotroski score
₹6.0
Graham Number
852.0
No. Eq. Shares
58.6
Net CF
₹2,178
Net profit
3,390
Price to book value
1.95
Interest Coverage
₹12.2
Low price all time
10.1
Industry PE
33.8
Reserves
₹32,595
Free Cash Flow
₹1,408

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
AUROBINDO PHARMA LTD.29319.45591.328481.79.6363,98419.0
GLENMARK PHARMACEUTICALS LTD.24642.633302.2623949.2811.75489741.2
BIOCON LTD.5984.0-83.05371.0-0.0748659134.0

Peer Comparison Chart


About AUROBINDO PHARMA

Aurobindo Pharma Ltd., with Security Code 524804, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Aurobindo Pharma Ltd soars 1.82%

(13 Aug 2025)
Aurobindo Pharma Ltd is quoting at Rs 1077.5, up 1.82% on the day as on 12:49 IST on the NSE. The stock is down 29.1% in last one year as...
Read more →

Aurobindo Pharma AGM scheduled

(13 Aug 2025)
Aurobindo Pharma announced that the Annual General Meeting(AGM) of the company will be held on 10 September 2025. More News. Company Logo.
Read more →

Aurobindo Pharma Q1 FY26 PAT slips 10% YoY to Rs. 824 Cr

(10 Aug 2025)
Aurobindo Pharma Limited has reported a consolidated net profit of Rs. 824 crore in the quarter ended June 2025 (Q1 FY26) against Rs. 918...
Read more →

Aurobindo Pharma Q1 Results Review: Motilal Oswal Maintains Buy — Check Target Price

(06 Aug 2025)
Aurobindo Pharma delivered lower-than-expected performance for Q1 FY26. While revenue was in line with estimates, Ebitda/PAT missed...
Read more →

Stock Picks Today: Escorts Kubota, Marico, IndusInd Bank, Aurobindo Pharma On Brokerages Radar

(05 Aug 2025)
Escorts Kubota Ltd., Sona BLW Precision Forgings Ltd., LIC Housing Finance Ltd., Marico Ltd., Shree Cement Ltd., IndusInd Bank Ltd.,...
Read more →

Aurobindo Pharma Q1 Updates: Net Profit slips 10.20% y-o-y

(05 Aug 2025)
Aurobindo Pharma Limited announced mixed performance during the quarter ended June 2025. The business reported a consolidated net profit of...
Read more →

Company Updates